Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROM SSCOL: HPV Vaccination Program in Middle Schools
NCT04459221Phase 4Completed
- Sponsor
- CHU de La Réunion
- Start
- Nov 2020
- Primary completion
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by CHU de La Réunion. Started Nov 2020; status: completed.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT04459221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04459221.